Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
about
Role of Circulating Tumor Cell (CTC) Monitoring in Evaluating Prognosis of Triple-Negative Breast Cancer Patients in China.Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.Bone metastasis risk factors in breast cancer.Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.Characterization of bone only metastasis patients with respect to tumor subtypes.Artificial neural network based gynaecological image-guided adaptive brachytherapy treatment planning correction of intra-fractional organs at risk dose variation.
P2860
Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Evaluation of clinical paramet ...... e metastasis in breast cancer.
@ast
Evaluation of clinical paramet ...... e metastasis in breast cancer.
@en
type
label
Evaluation of clinical paramet ...... e metastasis in breast cancer.
@ast
Evaluation of clinical paramet ...... e metastasis in breast cancer.
@en
prefLabel
Evaluation of clinical paramet ...... e metastasis in breast cancer.
@ast
Evaluation of clinical paramet ...... e metastasis in breast cancer.
@en
P2093
P2860
P1433
P1476
Evaluation of clinical paramet ...... e metastasis in breast cancer.
@en
P2093
Achim Wöckel
Catharina Bartmann
Joachim Diessner
Lukas Schwentner
Manfred Wischnewsky
Mathias Krockenberger
Roland Stein
Rolf Kreienberg
Sebastian Häusler
Tanja Stüber
P2860
P2888
P356
10.1186/S12885-016-2345-7
P407
P577
2016-05-12T00:00:00Z
P6179
1044666458